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Abstract
Sudden cardiac death (SCD) is the leading cause of death in athletes. A large
proportion of these deaths are associated with undiagnosed cardiovascular dis-
ease. Screening for high-risk individuals enables early detection of pathology, as
well as permitting lifestyle modification or therapeutic intervention.
ECG changes in athletes occur as a result of electrical and structural adaptations
secondary to repeated bouts of exercise. Such changes are common and may
overlap with patterns suggestive of underlying cardiovascular disease. Correct
interpretation is therefore essential, in order to differentiate physiology from
pathology. Erroneous interpretation may result in false reassurance or expensive
investigations for further evaluation and unnecessary disqualification from com-
petitive sports.
Interpretation of the athlete’s ECG has evolved over the past 12 years, beginning
with the 2005 European Society of Cardiology (ESC) consensus, progressing to the
ESC recommendations (2010), Seattle Criteria (2013) and the ‘refined’ criteria
(2014). This evolution culminated in the recently published international recom-
mendations for ECG interpretation in athletes (2017), which has led to a signif-
icant reduction in false positives and screening-associated costs. This review aims
to describe the evolution of the current knowledge on ECG interpretation as well
as future directions.
Introduction
An athlete is defined as ‘one who participates in an
organised team or individual sport requiring systematic
training and regular competition against others, while
placing a high premium on athletic excellence and
achievement’ [1]. The sudden death of an athlete is a
tragic event which is often highly publicised, particularly
as athletes represent the healthiest individuals within
society.
Sudden cardiac death (SCD) is the leading cause of
death in athletes [2, 3] and a large proportion of these
deaths are associated with undiagnosed cardiovascular
disease [4, 5]. Young athletes demonstrate a 2.5-fold
increased risk of SCD compared to sedentary individuals
suggesting that sporting activity acts as a trigger for life-
threatening arrhythmias in those with an underlying
substrate [6]. The rate of SCD has previously been
thought to be in the region of 1 in 50, 000 [2]. However,
a recent study of 11, 000 adolescent football players
identified an incidence of SCD of closer to 6.8 per
100,000 athletes [7].
Screening enables early detection of underlying car-
diovascular disease, as well as enabling lifestyle modifi-
cation and therapeutic intervention. A pre-participation
screening programme comprising of history, physical
examination and 12-lead ECG has been in practice in
Italy for over 30 years [8]. This has led to an 89%
reduction in SCD [9], primarily due to improved iden-
tification of cardiomyopathies through cessation of on-
going competitive physical activity. Most individuals at
risk will not be identified from their history and exam-
ination alone, given that 80% are asymptomatic with
SCD often the first presentation of underlying cardio-
vascular pathology [10]. On the contrary, ECG changes
may be seen in up to 95% of patients with hypertrophic
cardiomyopathy (HCM) and 80%of those with arrhyth-
mogenic right ventricular cardiomyopathy (ARVC) [11].
Thus, use of the ECG improves the detection of early
electrical changes which precede phenotypic expression.
In addition, the ECG is essential to detect electrical
conditions such as long QT syndrome, Brugada syn-
drome and Wolff-Parkinson-White (WPW) syndrome.
ECG adaptations in athletes are common and occur
as a result of electrical and structural remodelling in
response to repeated bouts of intense training regimes
[12–18]. It is essential that an athlete’s ECG is correctly
interpreted in order to differentiate physiological chang-
es from pathology [19, 20]. Incorrect interpretation may
result in an expensive diagnostic work up and unneces-
sary disqualification from competitive sports. This has
significant psychological as well as financial implica-
tions for an affected individual. Conversely, if patholog-
ical changes are reported as normal, an athlete may be
falsely reassured with potentially fatal consequences.
Interpretation of the athlete’s ECG has developed
over time owing to new data and refinement of criteria
based on validation in large and diverse cohorts. This
has resulted in a significant reduction in false positives
[21] and screening-associated costs [22]. This review
aims to describe the evolution of current knowledge
on ECG interpretation as well as highlight future direc-
tions in cardiac screening.
ESC consensus statement (2005)
The first consensus statement regarding ECG interpretation in an athlete was
compiled by the European Society of Cardiology (ESC) [23]. The group
consisted of cardiovascular specialists and physicians from Europe. The criteria
were predominantly based on individual expertise and small cohort experience
and outlined the ECG phenotypes warranting further investigation (Fig. 1).
Revised ESC recommendations (2010)
When applying the guidelines from the ESC consensus (2005), ECGs were found to
be ‘abnormal’ in up to 50% of athletes [24] resulting in an unacceptably high false
positive rate. The revised ESC criteria in 2010 divided ECG changes into common
104 Page 2 of 10 Curr Treat Options Cardio Med (2018) 20: 104
and training-related (group 1) and training-unrelated (group 2) changes (Fig. 1).
The group 1 changes have formed the basis for current ECG findings
suggestive of normal athletic adaptation. Increased vagal tone in athletes can
lead to sinus arrhythmia, first degree atrioventricular (AV) block (PR interval 9
200ms) andMobitz type I AV block [25–27]. However,Mobitz type II and third
degree AV block are rare in an athlete [28]. Incomplete right bundle branch
block (RBBB) with a QRS duration G 120ms occurs in 30–50% in athletes [29].
This is thought to be caused by enlargement of the right heart in response to
training [29]. Early repolarisation is defined as elevation of the junction be-
tween theQRS-ST segments≥ 0.1mV [30] and is common in athletes. Although
there have been studies suggesting a correlation between early repolarisation
and ventricular fibrillation, there is still no conclusive evidence [31]. Voltage
criterion for left ventricular hypertrophy (LVH) (S wave V1 + R wave V5/V6 = ≥
35 mm) is common in athletes, and although it is also frequently observed on
the ECGs of patients with HCM, less than 2% demonstrate LVH in isolation
[32–34]. Voltage criterion for LVH in HCM is usually associated with other
features such as T-wave inversion (TWI) in the inferior and/or lateral leads, Q
waves and ST segment depression [35].
The Seattle Criteria (2013)
Despite the ESC 2010 recommendations improving the specificity of the
ECG to detect disease, the effect of ethnicity was unaccounted for. Black
athletes are increasingly competing at every level of sport yet an alarmingly
high number of false positive ECGs were being identified in this group [36].
The Seattle criteria were devised to help address this issue, by an interna-
tional group of sports cardiologists who convened to update current criteria
for ECG interpretation. Normal and abnormal ECG findings according to the
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Fig. 1. Evolution of the interpretation of the athlete’s ECG.
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Seattle criteria are summarised in Fig. 1. In addition to the common training-
related findings originally listed in the ESC recommendations, the Seattle
criteria also included ethnicity-specific ECG changes. Convex ST segment
elevation combined with T-wave inversion (TWI) in leads V1-V4 in black
athletes was classified as a normal ethnic variant. This was based on a study
of 904 black athletes who were compared to white athletes, black controls
and black HCM patients [37]. Anterior TWI (V1-V4) were present in 12.7%
of black athletes with lower prevalence in black controls and HCM patients.
In contrast to lateral TWI, anterior TWI was not associated with pathology.
The Seattle Criteria also redefined several existing abnormal ECG parameters
(Table 1).
Less conservative cut-offs for an abnormal QT interval were adopted by the
Seattle criteria with an upper limit of 470 ms in males and 480 ms in females.
This was based on a study of 2000 elite athletes, 0.4% of whom had a QT
interval of 460–570ms. In the absence of symptoms or family history, a QTc of
G 500 ms was unlikely to represent pathology [38]. Moreover, the QT interval
for short QT was reduced to less than 320 ms. This has been proposed as an
arbitrary cut-off based on data from over 18,000 asymptomatic individuals
[39]. The authors also recommended further investigation in those athletes with
≥ 2 premature ventricular ectopics (VEs) as multiple VEs are uncommon in
athletes and present in G 1% [40].
The ‘Refined Criteria’ (2014)
Subsequent to the publication of the Seattle criteria, evidence emerged that
certain ECG changes assigned to the training-unrelated group, in isolation
may not be representative of pathology. The ‘refined criteria’, [41] for the
first time, included right (p wave 9 2.5 mm in II, II and aVF), left atrial
enlargement (p wave 9 120 ms in I and II with the negative portion of the p
wave ≥ 1 mm in depth and ≥ 40 ms in duration in V1), right and left axis
deviation (− 30 to − 90°) and right ventricular hypertrophy (RVH) (R wave
in V1 + S wave in V5 = ≥ 10.5 mm) in a borderline variant category. A large
study of over 2000 athletes and nearly 10,000 controls identified that in
Table 1. Abnormal ECG parameters
ESC guidelines Seattle criteria
TWI ≥ 2 mm in ≥ 2 adjacent leads(deep) or
minor in ≥ 2 leads
TWI 9 1 mm in depth in two or more leads V2-V6, II and aVF, or I and aVL
(excluding III, aVR)
Pathological Q waves 9 4 mm deep in any
lead except II and aVR
Pathological Q waves 9 3 mm in depth or 9 40 ms in duration in two or more
contiguous leads except III and aVR
Right axis deviation 9 115° Right axis deviation 9 120°
Not defined Profound sinus bradycardia G 30 bpm
PR interval G 120 ms with or without a delta
wave
PR interval G 120 ms with a delta wave
Intraventricular conduction delay 9 120 ms Intraventricular conduction delay 9 140 ms
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those with isolated axis deviation or atrial enlargement there were no
significant functional or structural abnormalities [42]. Moreover, similar
to LVH, isolated RVH has not been shown to correlate with pathology
[43]. The authors defined the presence of two or more borderline variants
as abnormal, warranting further investigation (Fig. 1).
The effectiveness of the ‘refined’ criteria was also validated in a cohort of 1208
black athletes, 4297 white athletes and 103 athletes with HCM. The performance
of the ‘refined’ criteria was compared to the ESC recommendations and Seattle
criteria [41]. All three criteria identified 98.1% of those with HCM, indicating
similar sensitivity in detecting cardiac pathology. The use of the ‘refined’ criteria
reduced abnormal ECGs to 11.5% in black athletes and 5.3% in white athletes
thus improving the specificity of the ESC recommendations from 40.3 to 82.4%
in black athletes and 73.8 to 94.1% in white athletes.
International recommendations for electrocardiographic
interpretation in athletes
The evolution of the interpretation of the athlete’s ECG has culminated in the
recent publication of the international recommendations for ECG interpreta-
tion in athletes [44] (Fig. 2).
Building on previous criteria, the international recommendations also in-
cluded the juvenile ECG pattern, up to the age of 16 years, as a normal ECG
finding [45, 46]. The authors also reclassified TWI in V1-V4 with preceding
convex ST elevation in black athletes as a normal finding.
The international recommendations redefined abnormal TWI to be that
which extended beyond V2. This was based on a large study of 14,000 Cauca-
sians which demonstrated that anterior TWI had a prevalence of 2.3%, was
Fig. 2. International recommendations for ECG interpretation in athletes.
Curr Treat Options Cardio Med (2018) 20: 104 Page 5 of 10 104
more common in females and athletes and was confined to V1 and V2 in most.
TWI only extended beyond V2 in 1% of females and 0.2% of males [47]. Other
additions to abnormal ECG findings included a PR interval of 9 400 ms, and
only the type I Brugada pattern was considered to be diagnostic (coved RSR
pattern which has ST segment elevation ≥ 2 mm and inversion of the terminal
portion of the T wave in V1, V2 and V3) [48].
RBBB was added to the borderline category, although the evidence for wheth-
er RBBB is pathological in the long term is lacking [49]. A single study of 510 US
athletes showed that athletes with RBBB had larger LV dimensions, a reduced
ejection fraction but the fractional area change was preserved. They did not
display any evidence of pathology [50]. Unlike RBBB, left bundle branch block
(LBBB) is found in G 1000 athletes [35, 49] and therefore should be considered
pathological until proven otherwise. Finally, Q waves were redefined as a Q/R
ratio of ≥ 0.25 or ≥ 40 ms in two or more contiguous leads (except III and aVR).
Discussion
The evolution of ECG guidelines has enhanced identification of cardiovascular
pathology and dramatically reduced false positives. This has not only benefitted
specialists but also physicians with limited experience within the field of sports
cardiology [51, 52]. Revision of the criteria has also resulted in significant cost
savings [53]. A recent paper [22] compared the costs associated with the use of
the ESC recommendations, Seattle criteria and ‘refined’ criteria. The number of
abnormal ECGs, most of which were false positives reduced from 11.2 to 6%
with the Seattle criteria and 4.3% with the ‘refined’ criteria. The reduction in the
number of false positives was associatedwith a 20% cost reduction of screening,
from $110 per athlete with the ESC to $92 and $87 per athlete, with the Seattle
and ‘refined’ criteria, respectively.
Although there have been considerable advances in the interpretation
of the athlete’s ECG, there remain areas which require further clarification.
The significance of indices such as biphasic TWI, isolated inferior TWI and
RBBB in athletes is not well understood, [49] and further investigation of
the athlete is currently advised. It also remains unclear how to differentiate
a black athlete’s ECG from arrhythmogenic cardiomyopathy as both are
characterised by anterior TWI. A recent study by Calore et al. attempted to
identify novel ECG markers of pathology to resolve this issue. The authors
showed that in athletes anterior J point elevation ≥ 1 mm preceding TWI in
leads V1-V4 excluded cardiomyopathy with 100% negative predictive value
[54], and suggested that anterior TWI associated with minimal or absent J
point elevation is suggestive of cardiomyopathy. However, more recent
studies have challenged that claim, as J-point elevation may be absent in
30% of male and 70% of female athletes. [48]
Consideration should also be given to the growing population of mixed
race athletes and veteran amateur athletes [55]. Mixed race athletes have
been poorly represented in existing studies and although black ethnicity
is reported as a single group, recent data suggest that this is far from the
truth, with black athletes of west and central African descent the ones more
likely to exhibit ECG anomalies. [56] Finally, long-term follow up studies of
104 Page 6 of 10 Curr Treat Options Cardio Med (2018) 20: 104
athletes are required in order to identify false negative rates, given that the
phenotypic manifestations of certain conditions may occur later in life.
Conclusion
Interpretation of the ECG has undergone significant modifications over the last
two decades. As a result, the false positive rates and associated costs have
dramatically declined. There appears to be scope to further refinement of the
ECG criteria in order to improve sensitivity and specificity. One must however,
pay heed to limitations of the ECG which may not demonstrate certain pathol-
ogies such as premature coronary disease, aortopathies and anomalous coro-
nary arteries. Moreover, ECGs in patients with underlying pathology may be
normal. Therefore, although the guidelines serve as an important reference for
clinicians, the ECG should be interpreted in the context of symptoms, family
history and personal experience. Where possible, assessment should be per-
formed by a specialist with knowledge and experience of inherited cardiac
conditions and sports cardiology.
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